Skip to main content
IGC logo

IGC Pharma, Inc.

IGCNYSEAMERICANHealthcareBiotechnology

$0.25Today:- (-)1Y −34.30%

As of Oct 26, 2026 close

Market cap
$25.07M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.24$0.45
Volume (live)
-
Avg. volume (3M)
585.33K

IGC Pharma (IGC) Financial Ratios

For fiscal 2025 (fiscal year ended Mar 31, 2025), IGC Pharma had return on equity of -104.3% (up from -117.0%), debt-to-equity of 0.04 (down from 0.05), a current ratio of 1.28 (down from 1.58) and return on assets of -49.9% (down from -45.2%). A current ratio of 1.28 means current assets exceed current liabilities.

IGC Pharma Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period endingMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Valuation Ratios
Forward P/E4.354.354.354.354.35
P/S Ratio17.8719.6519.78122.0390.43
P/B Ratio3.593.611.212.032.48
Price/Tangible Book5.074.631.312.112.51
PEG Ratio2.262.262.262.262.26
Enterprise Value Ratios
EV/Revenue17.7118.9114.8293.5788.34
Profitability & Returns
Return on Equity (ROE)-104.33%-116.95%-59.30%-52.97%-29.70%
Return on Assets (ROA)-49.91%-45.23%-32.86%-29.10%-16.81%
Return on Capital Employed (ROCE)-114.70%-129.60%-75.70%-59.80%-26.00%
Leverage & Solvency Ratios
Debt/Equity0.040.050.030.030.03
Liquidity Ratios
Current Ratio1.281.583.416.199.93
Quick Ratio0.210.551.834.536.27
Efficiency Ratios
Asset Turnover0.140.100.040.010.03
Inventory Turnover0.450.290.150.040.14
Yield & Distribution Ratios
Earnings Yield-31.36%-49.20%-63.85%-31.00%-10.85%
FCF Yield-21.61%-20.20%-40.83%-15.89%-15.11%
Buyback Yield-30.04%-11.91%-5.17%-19.13%-6.26%

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About IGC Pharma Financial Ratios

What is IGC Pharma's return on equity?

IGC Pharma's return on equity (ROE) was -104.3% for fiscal 2025 (period ended Mar 31, 2025). It was -117.0% a year earlier.

What is IGC Pharma's debt-to-equity ratio?

IGC Pharma's debt-to-equity ratio was 0.04 for fiscal 2025 (period ended Mar 31, 2025). It was 0.05 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition